Double-blind, randomized, placebo-controlled, Single-center, Exploratory Clinical Trial to Investigate Safety and Efficacy of COMBOPROFEN for treatment of muscular pain associated with DOMS

Trial Profile

Double-blind, randomized, placebo-controlled, Single-center, Exploratory Clinical Trial to Investigate Safety and Efficacy of COMBOPROFEN for treatment of muscular pain associated with DOMS

Recruiting
Phase of Trial: Phase II

Latest Information Update: 25 Jul 2017

At a glance

  • Drugs Ascorbic acid/ibuprofen/magnesium (Primary) ; Ascorbic acid; Ibuprofen; Magnesium
  • Indications Muscle pain
  • Focus Therapeutic Use
  • Sponsors Spherium Biomed
  • Most Recent Events

    • 13 Jun 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top